References
- Fung LK, Mahajan R, Nozzolillo A, et al. Pharmacologic treatment of severe irritability and problem behaviors in autism: a systematic review and meta-analysis. Pediatrics 2016;137(Suppl 2): S124–S135.
- Aman MG. Treatment of severe childhood aggression (TOSCA) studies. J Child Adolesc Psychopharmacol. 2015;25:201–202.
- van Schalkwyk GI, Lewis AS, Beyer C, et al. Efficacy of antipsychotics for irritability and aggression in children: a meta-analysis. Expert Rev Neurother. 2017;17:1045–1053.
- Nesvag R, Bramness JG, Handal M, et al. The incidence, psychiatric co-morbidity and pharmacological treatment of severe mental disorders in children and adolescents. Eur Psychiatry. 2018;49:16–22.
- Chen W, Cepoiu-Martin M, Stang A, et al. Antipsychotic prescribing and safety monitoring practices in children and youth: a population-based study in Alberta, Canada. Clin Drug Investig. 2018;38:449–455.
- Meli M, Rauber-Luthy C, Hoffmann-Walbeck P, et al. Atypical antipsychotic poisoning in young children: a multicentre analysis of poison centres’ data. Eur J Pediatr. 2014;173:743–750.
- Stassinos G, Klein-Schwartz W. Comparison of pediatric atypical antipsychotic exposures reported to U.S. poison centers. Clin Toxicol (Phila). 2017;55:40–45.
- Taxonomy of Medication Errors. |Internet]. National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP). 2001 Jul 31 [cited 2018 Aug 13]; [about 23 screens]. Available from http://www.nccmerp.org/sites/default/files/taxonomy2001-07-31.pdf
- Thyssen A, Vermeulen A, Fuseau E, et al. Population pharmacokinetics of oral risperidone in children, adolescents and adults with psychiatric disorders. Clin Pharmacokinet. 2010;49:465–478.
- Persson HE, Sjoberg GK, Haines JA, et al. Poisoning severity score. Grading of acute poisoning. J Toxicol Clin Toxicol. 1998;36:205–213.
- Puangpetch A, Vanwong N, Nuntamool N, et al. CYP2D6 polymorphisms and their influence on risperidone treatment. Pharmgenomics Pers Med. 2016;9:131–147.
- Loy JH, Merry SN, Hetrick SE, et al. Atypical antipsychotics for disruptive behaviour disorders in children and youths. Cochrane Database Syst Rev 2017;8:CD008559.
- Caccia S, Clavenna A, Bonati M. Antipsychotic drug toxicology in children. Expert Opin Drug Metab Toxicol. 2011;7:591–608.
- Carton L, Cottencin O, Lapeyre-Mestre M, et al. Off-Label prescribing of antipsychotics in adults, children and elderly individuals: a systematic review of recent prescription trends. CPD. 2015;21:3280–3297.
- Glennon J, Purper-Ouakil D, Bakker M, et al. Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges. Eur Child Adolesc Psychiatry. 2014;23:1149–1160.
- Palanca-Maresca I, Ruiz-Antoran B, Centeno-Soto G, et al. SENTIA: a systematic online monitoring registry for children and adolescents treated with antipsychotics. Springerplus. 2014;3:187.
- Antia SX, Sholevar EH, Baron DA. Overdoses and ingestions of second-generation antipsychotics in children and adolescents. J Child Adolesc Psychopharmacol. 2005;15:970–985.
- Glatstein M, Sulowski C, Waisburg C, et al. Severe extrapyramidal symptoms after nonintentional risperidone exposure in a child: case report and review of the literature. Am J Ther. 2011;18:e271–e273.
- Karaca S, Ozatalay E, Canan F. A case of risperidone overdose in a 4-year-old boy. Prim Care Companion CNS Disord. 2016;18:doi:10.4088/PCC.15l01855.
- Anderson KT, Caravati EM, Seger CJ. Serious toxicity in an infant due to ingestion of 1 mg risperidone. Clin Toxicol. 2008;46:629.
- Mas S, Gassó P, Lafuente A, et al. Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes. Pharmacogenomics J. 2016;16:439–445.
- Hoffman RS. Understanding the limitations of retrospective analyses of poison center data. Clin Toxicol. 2007;45:943–945.
- Brown K, Levy H, Brenner C, et al. Overdose of risperidone. Ann Emerg Med. 1993;22:1908–1910.
- Lo Vecchio F, Hamilton RJ, Hoffman RJ. Risperidone overdose. Am J Emerg Med. 1996;14:95–96.
- Moore NC, Shukla P. Risperidone overdose. Am J Psychiatry. 1997;154:289–290.
- Himstreet JE, Daya M. Hypotension and orthostasis following a risperidone overdose. Ann Pharmacother. 1998;32:267.
- Nishikage H, Nakanishi T, Takamitsu Y, et al. Sequential changes in the plasma concentration of risperidone following intentional overdose. Clin Neuropharmacol. 2002;25:307–309.
- Hodge CH, Jewell M, Gummin DD, et al. Atypical presentation of risperidone toxicity. Vet Hum Toxicol. 2001;43:339–341.
- Page CB, Calver LA, Isbister GK. Risperidone overdose causes extrapyramidal effects but not cardiac toxicity. J Clin Psychopharmacol. 2010; 30:387–390.